← Open Payments lookup

LUCAS WANGERIN: Open Payments

NPI 1487927257 · FORT CARSON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$815 in 37 payments from 20 companies in 2025. Trend: 2023 $39 · 2024 $432 · 2025 $815

Food & beverage: $815
CompanyPaymentsAmount
Novo Nordisk Inc6$127
Lilly USA, LLC7$125
AstraZeneca Pharmaceuticals LP4$91
Otsuka America Pharmaceutical, Inc.3$80
Amgen Inc.2$48
Medtronic, Inc.1$44
ABBVIE INC.1$34
Vanda Pharmaceuticals Inc.1$32
Astellas Pharma US Inc1$25
Edwards Lifesciences Corporation1$24

Products named: MOUNJARO, REXULTI, Ozempic, Rybelsus, SYMPLICITY G3, MAVYRET, FANAPT, KRYSTEXXA.

Industry payments across CO — which companies pay providers there.